Novel aminoglycoside 2″-phosphotransferase identified in a gram- negative pathogen

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 452-457

  Toth, Marta ^a   Frase, Hilary ^a   Antunes, Nuno T ^a   Vakulenko, Sergei B ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMIKACIN; AMINOGLYCOSIDE; AMINOGLYCOSIDE 2'' PHOSPHOTRANSFERASE; DIBEKACIN; GUANOSINE TRIPHOSPHATE; HABEKACIN; ISEPAMICIN; KANAMYCIN; NETILMICIN; PHOSPHOTRANSFERASE; SISOMICIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER JEJUNI; CATALYSIS; CONTROLLED STUDY; ENZYME KINETICS; ENZYME PHOSPHORYLATION; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; STEADY STATE;

AMINO ACID SEQUENCE; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CAMPYLOBACTER JEJUNI; CLONING, MOLECULAR; ENZYME ASSAYS; ESCHERICHIA COLI; KINETICS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 84872048832     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02049-12     Document Type: Article

References (37)

1. Wright GD, Berghuis AM, Mobashery S. 1998. Aminoglycoside antibiotics. Structures, functions, and resistance. Adv. Exp. Med. Biol. 456:27-69.
2. Mehta R, Champney WS. 2002. 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob. Agents Chemother. 46:1546 -1549.
3. Moazed D, Noller HF. 1987. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389 -394.
4. Ogle JM, Brodersen DE, Clemons WM, Jr, Tarry MJ, Carter AP, Ramakrishnan V. 2001. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292:897-902.
5. Vakulenko SB, Mobashery S. 2003. Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16:430-450.
6. Drusano GL, Ambrose PG, Bhavnani SM, Bertino JS, Nafziger AN, Louie A. 2007. Back to the future: using aminoglycosides again and how to dose them optimally. Clin. Infect. Dis. 45:753-760.
7. Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME. 2009. Do we still need the aminoglycosides? Int. J. Antimicrob. Agents 33:201-205.
8. Avent ML, Rogers BA, Cheng AC, Paterson DL. 2011. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern. Med. J. 41:441- 449.
9. Bryan LE, Kowand SK, van den Elzen HM. 1979. Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob. Agents Chemother. 15:7-13.
10. Moellering RC, Jr. 1991. The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J. Antimicrob. Chemother. 28:1-12.
11. Aires JR, Kohler T, Nikaido H, Plesiat P. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624 -2628.
12. Magnet S, Courvalin P, Lambert T. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45: 3375-3380.
13. Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465- 470.
14. Eliopoulos GM, Farber BF, Murray BE, Wennersten C, Moellering RC, Jr. 1984. Ribosomal resistance of clinical enterococcal isolates to streptomycin. Antimicrob. Agents Chemother. 25:398 -399.
15. Lacey RW, Chopra I. 1972. Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J. Gen. Microbiol. 73: 175-180.
16. Maness MJ, Foster GC, Sparling PF. 1974. Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae. J. Bacteriol. 120:1293-1299.
17. Beauclerk AA, Cundliffe E. 1987. Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides. J. Mol. Biol. 193:661- 671.
18. Courvalin P. 2008. New plasmid-mediated resistances to antimicrobial agents. Arch. Microbiol. 189:289 -291.
19. Doi Y, Arakawa Y. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45: 88-94.
20. Ramirez MS, Tolmasky ME. 2010. Aminoglycoside modifying enzymes. Drug Resist Updat. 13:151-171.
21. Chow JW. 2000. Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31:586 -589.
22. Badarau A, Shi Q, Chow JW, Zajicek J, Mobashery S, Vakulenko S. 2008. Aminoglycoside 2″-phosphotransferase type IIIa from Enterococcus. J. Biol. Chem. 283:7638 -7647.
23. Toth M, Chow JW, Mobashery S, Vakulenko SB. 2009. Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2″-phosphotransferases. J. Biol. Chem. 284:6690-6696.
24. Toth M, Frase H, Antunes NT, Smith CA, Vakulenko SB. 2010. Crystal structure and kinetic mechanism of aminoglycoside phosphotransferase- 2″-IVa. Protein Sci. 19:1565-1576.
25. Toth M, Zajicek J, Kim C, Chow JW, Smith C, Mobashery S, Vakulenko S. 2007. Kinetic mechanism of enterococcal aminoglycoside phosphotransferase 2″-Ib. Biochemistry 46:5570 -5578.
26. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 8th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
27. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. 2003. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31:3784 -3788.
28. Dixon M. 1953. The determination of enzyme inhibitor constants. Biochem. J. 55:170 -171.
29. Copeland RA. 2000. Enzymes: a practical introduction to structure, mechanism, and data analysis, 2nd ed. J. Wiley, New York, NY.
30. Smith CA, Toth M, Frase H, Byrnes LJ, Vakulenko SB. 2012. Aminoglycoside 2″-phosphotransferase IIIa (APH(2″)-IIIa) prefers GTP over ATP: structural templates for nucleotide recognition in the bacterial ami-noglycoside- 2″ kinases. J. Biol. Chem. 287:12893-12903.
31. Young PG, Walanj R, Lakshmi V, Byrnes LJ, Metcalf P, Baker EN, Vakulenko SB, Smith CA. 2009. The crystal structures of substrate and nucleotide complexes of Enterococcus faecium aminoglycoside-2″- phosphotransferase-IIa [APH(2″)-IIa] provide insights into substrate selectivity in the APH(2″) subfamily. J. Bacteriol. 191:4133- 4143.
32. Nirdnoy W, Mason CJ, Guerry P. 2005. Mosaic structure of a multiple-drug- resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob. Agents Chemother. 49:2454 -2459.
33. Kondo S, Hotta K. 1999. Semisynthetic aminoglycoside antibiotics: development and enzymatic modifications. J. Infect. Chemother. 5:1-9.
34. Martel A, Masson M, Moreau N, Le Goffic F. 1983. Kinetic studies of aminoglycoside acetyltransferase and phosphotransferase from Staphylococcus aureus RPAL. Relationship between the two activities. Eur. J. Biochem. 133:515-521.
35. Daigle DM, Hughes DW, Wright GD. 1999. Prodigious substrate specificity of AAC(6′)-APH(2″), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci. Chem. Biol. 6:99 -110.
36. Kim C, Cha JY, Yan H, Vakulenko SB, Mobashery S. 2006. Hydrolysis of ATP by aminoglycoside 3′-phosphotransferases: an unexpected cost to bacteria for harboring an antibiotic resistance enzyme. J. Biol. Chem. 281: 6964-6969.
37. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.